Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Self-directed Titrated Transdermal Nicotine Patch Versus Standard Treatment for Smoking Cessation in Smokers Motivated to Quit

NCT01622998 is registered in ClinicalTrials.gov with Ottawa Heart Institute Research Corporation as lead sponsor.

NCT NCT01622998
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01622998 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Self-directed Titrated Transdermal Nicotine Patch Versus Standard Treatment for Smoking Cessation in Smokers Motivated to Quit
Lead sponsor
Ottawa Heart Institute Research Corporation
Phase
Phase 4
Overall status
Completed
Start date
January 31, 2011
Completion date
September 30, 2014
Enrollment
303 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

smoking cessation